Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Hepatocellular Carcinoma”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Early research (Phase 1)Active Not RecruitingNCT03655002
What this trial is testing

IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaRefractory Liver CarcinomaStage IV Hepatocellular Carcinoma AJCC v8+2 more
City of Hope Medical Center 8
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT04676633
What this trial is testing

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCholangiocarcinoma
Sirnaomics 5
Early research (Phase 1)Study completedNCT03538028
What this trial is testing

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Who this might be right for
Cervical CancerMicrosatellite Instability (MSI)-High Endometrial CancerGastric Cancer (Including Stomach and Gastroesophageal Junction [GEJ])+14 more
Incyte Biosciences International Sàrl 22
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Looking for participantsNCT06789848
What this trial is testing

Ligufalimab and Cadonilimab in Advanced Liver Cancers

Who this might be right for
Advanced Hepatocellular CarcinomaRefractory Hepatocellular CarcinomaBiliary Tract Cancer
University of Texas Southwestern Medical Center 64
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Early research (Phase 1)Looking for participantsNCT06883539
What this trial is testing

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Who this might be right for
Solid Tumor Malignancies, CancerSolid CancersSolid Tumor Cancer+6 more
LaunXP Biomedical Co., Ltd. 24
Not applicableUnknownNCT05718882
What this trial is testing

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Who this might be right for
Liver CancerHepatocellular CarcinomaResistant Cancer
RenJi Hospital 30
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Looking for participantsNCT07500220
What this trial is testing

Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer
Beijing Biotech 30
Not applicableUnknownNCT04640116
What this trial is testing

TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites

Who this might be right for
Liver DiseasesPortal HypertensionCirrhosis, Liver+2 more
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT04634357
What this trial is testing

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

Who this might be right for
HepatoblastomaHepatocellular Carcinoma (HCC)Liver Neoplasms+3 more
Eureka Therapeutics Inc. 15
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Study completedNCT02159989
What this trial is testing

Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)Ended earlyNCT03785210
What this trial is testing

Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerMetastatic Pancreatic Cancer+2 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Not Yet RecruitingNCT06822985
What this trial is testing

QL1706 As Second-line Treatment in Patients with Advanced Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Wan-Guang Zhang 21
Early research (Phase 1)Temporarily pausedNCT06968195
What this trial is testing

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaRecurrent Hepatocellular Carcinoma+3 more
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT04767906
What this trial is testing

Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors

Who this might be right for
Hepatocellular Carcinoma
University of Leipzig 16
Load More Results